Use of secondary prevention pharmacotherapy after first myocardial infarction in patients with diabetes mellitus

BACKGROUND: Despite recommended pharmacotherapies the use of secondary prevention therapy after myocardial infarction (MI) remains suboptimal. Patients with diabetes mellitus (DM) have worse prognosis after MI compared to patients without DM and aggressive secondary prevention pharmacotherapy in thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Jørgensen, Casper H, Gislason, Gunnar H, Ahlehoff, Ole, Andersson, Charlotte, Torp-Pedersen, Christian, Hansen, Peter R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3897983/
https://www.ncbi.nlm.nih.gov/pubmed/24406095
http://dx.doi.org/10.1186/1471-2261-14-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3897983/
https://www.ncbi.nlm.nih.gov/pubmed/24406095
http://dx.doi.org/10.1186/1471-2261-14-4

Ejemplares similares